Skip to main content
SpringerLink
Log in

Interactions of Retinoids and Transforming Growth Factor-Beta in the Chemoprevention of Cancer

  • Conference paper
Control of Growth Factors and Prevention of Cancer

Part of the book series: ESO Monographs ((ESO MONOGRAPHS))

Abstract

Several years ago, we suggested that some new approaches are necessary if we intend to solve the problem of epithelial cancer in humans [1]. The conventional clinical approach that has been followed with most epithelial cancer has been to wait until the patient has invasive disease and then treat this disease with cytotoxic chemotherapy, surgery, or radiation. None of these modalities has been uniquely successful for the treatment of all types of epithelial cancer, in spite of some advances that have occurred. In the conventional approach to the disease, cancer is treated as if it were an entity that could be destroyed or removed, ignoring the evidence that cancer is a diffuse, evolutionary, developmental process [2]. What is called “cancer” in clinical incidence statistics is the process in its terminal stages; by this time many of the physiological controls that allow for orderly epithelial growth have been lost.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sporn MB: Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 1976 (36):2699–2702

    PubMed  CAS  Google Scholar 

  2. Foulds L: Neoplastic Development. Academic Press, New York 1969 p 439

    Google Scholar 

  3. Wellings SR, Jensen HM and Marcum RG: An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. JNC11975 55:231–273

    Google Scholar 

  4. Fontana RS, Sanderson DR, Woolner LB, Miller WE, Bernatz PE, Payne WS and Taylor WF: The Mayo lung project for early detection and localization of bronchogenic carcinoma: A status report. Chest 1975 (67):511–522

    Article  PubMed  CAS  Google Scholar 

  5. Auerbach O, Gere JB, Pawlowski JM, Muehsam GE, Smolin HJ and Stout AP: Carcinoma-in situ and early invasive carcinoma occurring in the tracheobronchial trees in cases of bronchial carcinoma. J Thoracic Surg 1957 (34):298–309

    CAS  Google Scholar 

  6. Koss LG, Tiamson EM and Robbins MA: Mapping cancerous and precancerous bladder changes. JAMA 1974 (227):281–286

    Article  PubMed  CAS  Google Scholar 

  7. Farber E and Rubin H: Cellular adaptation in the origin and development of cancer. Cancer Res 1991 (51):2751–2761

    PubMed  CAS  Google Scholar 

  8. Barron BA and Richart RM: A statistical model of the natural history of cervical carcinoma based on a prospective study of 557 cases. JNCI 1968 (41):1343–1353

    PubMed  CAS  Google Scholar 

  9. Farber E: Pathogenesis of liver cancer. Arch Pathol 1974 (98):145–148

    PubMed  CAS  Google Scholar 

  10. Auerbach O, Stout AP, Hammond EC and Garfinkel L: Bronchial epithelium in former smokers. N Engl J Med 1962 (267):119–125

    Article  Google Scholar 

  11. Furth J: Hormones as etiological agents in neoplasia. In: Becker FF (ed) Cancer, a Comprehensive Treatise. Plenum Publishing Corp, New York 1975 pp 109

    Google Scholar 

  12. Fenoglio CM and Lane N: The anatomic precursor of colorectal carcinoma. J Am Med Assoc 1975 (231):640–642

    Article  CAS  Google Scholar 

  13. Richart RM: A radio autographic analysis of cellular proliferation in dysplasia and carcinoma in situ of the uterine cervix. Am J Obstet Gynecol 1963 (86):925–930

    PubMed  CAS  Google Scholar 

  14. Boutwell RK: Function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol 1974 (2):419–443

    Article  PubMed  CAS  Google Scholar 

  15. Cairns J: Mutation selection and the natural history of cancer. Nature 1975 (255):197–200

    Article  PubMed  CAS  Google Scholar 

  16. Huggins C, Grand LC and Brillantes FP: Mammary cancer induced by a single feeding of polynuclear hydrocarbon, and its suppression. Nature 1961 (189):204–207

    Article  PubMed  CAS  Google Scholar 

  17. Jensen EV: Some newer endocrine aspects of breast cancer. N Engl J Med 1974 (291):1252–1254

    Article  PubMed  CAS  Google Scholar 

  18. Sporn MB, Dunlop NM, Newton DL and Smith JM: Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs retinoids. Fed Proc 1976 (35):1332–1338

    PubMed  CAS  Google Scholar 

  19. Wolbach SB and Howe PR: Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med 1925 (42):753–777

    Article  PubMed  CAS  Google Scholar 

  20. Clayson DB and Cooper EH: Cancer of the urinary tract. Adv Cancer Res 1970 (13):271–381

    Article  PubMed  CAS  Google Scholar 

  21. Schreiber H, Martin DH and Pazmino N: Species differences in the effect of benzo(alpha)pyrene-ferric oxide on the respiratory tract of rats and hamsters. Cancer Res 1975 (35):1654–1661

    PubMed  CAS  Google Scholar 

  22. Harris CC, Silverman T, Smith JM, Jackson F and Boren HG: Proliferation of tracheal epithelial cells in normal and vitamin A-deficient Syrian golden hamsters. JNC11973 51:1059–1062

    Google Scholar 

  23. Sporn MB and Roberts AB: Interactions of retinoids and transforming growth factor-6 in regulation of cell differentiation and proliferation. Mol Endocrinol 1991 (5):3–7

    Article  PubMed  CAS  Google Scholar 

  24. Assoian RK, Komoriya A, Meyers CA, Miller DM and Sporn MB: Transforming growth factor-6 in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983 (258):7155–7160

    PubMed  CAS  Google Scholar 

  25. Frolik CA, Dart LL, Meyers CA, Smith DM and Sporn MB: Purification and initial characterization of a type-6 transforming growth factor from human placenta. Proc Natl Acad Sci USA 1983 (80):3676–3680

    Article  PubMed  CAS  Google Scholar 

  26. Roberts AB, Anzano MA, Meyers CA, Wideman J, Blacher R, Pan YC, Stein S, Lehrman SR, Smith JM, Lamb LC and Sporn MB: Purification and properties of a type-6 transforming growth factor from bovine kidney. Biochemistry 1983 (22):5692–5698

    Article  PubMed  CAS  Google Scholar 

  27. Sporn MB and Roberts AB: Role of retinoids in differentiation and carcinogenesis. Cancer Res 1983 (43):3034–3040

    PubMed  CAS  Google Scholar 

  28. Roberts AB and Sporn MB: The transforming growth factors-8. In: Sporn MB and Roberts AB (eds) Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors. Vol. 95/1 Springer-Verlag, Heidelberg 1990 pp 419–472

    Google Scholar 

  29. Sporn MB and Roberts AB: TGF-6: Problems and prospects. Cell Regulation (1)990 1:875–882

    PubMed  CAS  Google Scholar 

  30. Massague J: The transforming growth factor-8 family. Ann Rev Cell Biol 1990 (6):597–641

    Article  PubMed  CAS  Google Scholar 

  31. Piez KA and Sporn MB: Transforming growth factor-8s: Chemistry, biology, and therapeutics. Ann N Y Acad Sci 1990 (593):379

    Article  Google Scholar 

  32. Bock G and Marsh J: Clinical applications of TGF-6. Ciba Foundation Symposium 157. John Wiley, Chichester and New York 1991 pp 254

    Google Scholar 

  33. Kim SJ, Glick A, Sporn MB and Roberts AB: Characterization of the promoter region of the human transforming growth factor-8 1 gene. J Biol Chem 1989 (264):402–408

    PubMed  CAS  Google Scholar 

  34. Lafyatis R, Lechleider R, Kim SJ, Jakowlew S, Roberts AB and Sporn MB: Structural and functional characterization of the transforming growth factor 83 promoter. A cAMP-responsive element regulates basal and induced transcription. J Biol Chem 1990 (265):19128–19136

    PubMed  CAS  Google Scholar 

  35. Fitzpatrick DR, Denhez F, Kondaiah P and Akhurst RJ: Differential expression of TGF-8 isoforms in murine palatogenesis. Development 1990 (109):585–595

    PubMed  CAS  Google Scholar 

  36. Pelton RW, Hogan BLM, Miller DA and Moses HL: Differential expression of genes encoding TGF-ßs 1, 2, and 3 during murine palate formation. Dev Biol 1990 (141):456–46Q

    Article  PubMed  CAS  Google Scholar 

  37. Sporn MB and Roberts AB: The multifunctional nature of peptide growth factors. In: Sporn MB and Roberts AB (eds) Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors. Vol 95/1 Springer-Verlag, Heidelberg 1990 pp 3–15

    Google Scholar 

  38. Wakefield LM and Sporn MB: Suppression of carcinogenesis: a role for TGF-ß and related molecules in prevention of cancer. In: Klein G (ed) Tumor Suppressor Genes. Marcel Dekker, New York 1990 pp 217–243

    Google Scholar 

  39. Glick AB, Flanders KC, Danielpour D, Yuspa SH and Sporn MB: Retinoic acid induces transforming growth factor-B2 in cultured keratinocytes and mouse epidermis. Cell Regulation (1)989 1:87–97

    PubMed  CAS  Google Scholar 

  40. Glick AB, McCune BK, Abdulkarem N, Flanders KC, Lumadue JA, Smith JM and Sporn MB: Complex regulation of TGF-ß expression by retinoic acid in the vitamin A-deficient rat. Development 1991 (111):1081–1086

    PubMed  CAS  Google Scholar 

  41. Tucker RF, Shipley GD, Moses HL and Holley RW: Growth inhibitor from BSC-1 cells closely related to platelet type-ß transforming growth factor from human platelets. Science 1984 (226):705–707

    Article  PubMed  CAS  Google Scholar 

  42. Silberstein GB and Daniel CW: Reversible inhibition of mammary gland growth by transforming growth factor-ß. Science 1987 (237):291–293

    Article  PubMed  CAS  Google Scholar 

  43. Russell WE, Coffey RJ, Ouellette AJ and Moses HL: Type-ß transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 1988 (85):5126–5130

    Article  PubMed  CAS  Google Scholar 

  44. Takahashi T, Nelson K, Goods L and Mclachlan JA: Transforming growth factor-ß promotes the growth of mouse uterus and vagina in vivo. J Cell Biochem 1989 (13bs):201

    Google Scholar 

  45. Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB and Roberts AB: Transforming growth factor-ß1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988 (263):7741–7746

    PubMed  Google Scholar 

  46. Bascom CC, Wolfshohl JR, Coffey RJ, Jr., Madisen L, Webb NR, Purchio AR, Derynck R and Moses HL: Complex regulation of transforming growth factor ß1, 2, and 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors-ß1 and ß2. Mol Cell Biol 1989 (9):5508–5515

    PubMed  CAS  Google Scholar 

  47. Kim SJ, Jeang KT, Glick A, Sporn MB and Roberts AB: Promoter sequences of the human TGF-ß gene responsive to TGF-ß1 autoinduction. J Biol Chem 1989 (264):7041–7045

    PubMed  CAS  Google Scholar 

  48. Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M and Roberts AB: Autoinduction of transforming growth factor-ß1 is mediated by the AP-1 complex. Mol Cell Biol 1990 (10):1492–1497

    PubMed  CAS  Google Scholar 

  49. Schule R, Umesono K, Mangelsdorf DJ, Bolado J, Pike JW and Evans RM: Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 1990 (61):497–504

    Article  PubMed  CAS  Google Scholar 

  50. Diamond Ml, Miner JN, Yoshinaga SK and Yamamoto KR: Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 1990 (249):1266–1272

    Article  PubMed  CAS  Google Scholar 

  51. Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H and Herrlich P: Antitumor promotion and anti-inflammation: Down-modulation of AP-1 Fos/Jun activity by glucocorticoid hormone. Cell 1990 (62):1189–1204

    Article  PubMed  CAS  Google Scholar 

  52. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J and Karin M: Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual Inhibition of DNA binding due to direct protein-protein interaction. Cell 1990 (62):1205–1215

    Article  PubMed  CAS  Google Scholar 

  53. SchHle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM and Evans RM: Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 1990 (62):1217–1226

    Article  Google Scholar 

  54. Mihara K, Cao XR, Yen A, Chandler S, Driscoll B, Murphree AL, T’Ang A and Fung YK: Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 1989 (246):1300–1303

    Article  PubMed  CAS  Google Scholar 

  55. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, MHnger K, Howley PM and Moses HL: TGF-61 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 1990 (61):777–785

    Article  PubMed  CAS  Google Scholar 

  56. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM and MassagDe J: Growth inhibition by TGF-8 linked to suppression of retinoblastoma protein phosphorylation. Cell 1990 (62):175–185

    Article  PubMed  CAS  Google Scholar 

  57. Kim SJ, Lee HD, Robbins PD, Busam K, Sporn MB and Roberts AB: Regulation of transforming growth factor-81 gene expression by the product of the retinoblastoma-susceptibility gene. Proc Natl Acad Sci USA 1991 (88):3052–3056

    Article  PubMed  CAS  Google Scholar 

  58. Robbins PD, Horowitz JM and Mulligan RC: Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature 1990 (346):668–671

    Article  PubMed  CAS  Google Scholar 

  59. Pollard M, Lucked PH and Sporn MB: Prevention of primary prostate cancer in Lobund-Wistar rats by (N-4-Hydroxyphenyl)retinamide. Cancer Res 1991 (51):3610–3611

    PubMed  CAS  Google Scholar 

  60. Moon RC, Thompson HJ, Becci PJ, Grubbs CJ, Gander RJ, Newton DL, Smith JM, Phillips SL, Henderson WR, Mullen LT, Brown CC and Sporn MB: N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res 1979 (39):1339–1346

    PubMed  CAS  Google Scholar 

  61. Moon RC, McCormick DL, Becci PJ, Shealy YF, Frickel F, Paust J and Sporn MB: Influence of 15 retinoic acid amides on urinary bladder carcinogenesis in the mouse. Carcinogenesis 1982 (3):1469–1472

    Article  PubMed  CAS  Google Scholar 

  62. Rotmensz N, De Palo G, Formelli F, Costa A, Marubini E, Campa T, Crippa A, Danesini GM, Grottaglie MD, Di Mauro MG, Filiberti A, Galazzi M, Guzzon A, Magni A, Malone W, Mariani L, Palvarini M, Perloff M, Pizzichetta M and Veronesi U: Long-term tolerability of fenretinide (4-HPR) in breast cancer patients. Eur J Cancer 1991 (in press)

    Google Scholar 

  63. Pollard M, Lückert PH and Snyder D: Prevention of prostate cancer and liver tumors in L-W rats by moderate dietary restriction. Cancer 1989 (64):686–690

    Article  PubMed  CAS  Google Scholar 

  64. Pollard M and Lückert PH: Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone. JNC11986 77:583–587

    Google Scholar 

  65. Pollard M and Lückert PH: Autochthonous prostate adenocarcinomas in Lobund-Wistar rats: a model system. Prostate 1987 (11):219–227

    Article  PubMed  CAS  Google Scholar 

  66. Pollard M, Lückert PH and Snyder DL: The promotional effect of testosterone on induction of prostate-cancer in MNU-sensitized L-W rats. Cancer Letter 1989 (45):209–212

    Article  CAS  Google Scholar 

  67. Pollard M, Lückert PH and Snyder D: Prevention and treatment of experimental prostate cancer in Lobund-Wistar rats. I. Effects of estradiol, dihydrotestosterone, and castration. Prostate 1989 (15):95–103

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Chemoprevention, National Cancer Institute, 20892, Bethesda, Maryland, USA

    Michael B. Sporn, Anita B. Roberts & Adam B. Glick

  2. Lobund Laboratory, University of Notre Dame, 46556, Notre Dame, Indiana, USA

    Phyllis H. Luckert & Morris Pollard

Authors
  1. Michael B. Sporn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anita B. Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adam B. Glick
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Phyllis H. Luckert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Morris Pollard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Laboratory of Chemoprevention, National Cancer Institute, Building 41, Room C-629, 20892, Bethesda, MD, USA

    Michael B. Sporn

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Sporn, M.B., Roberts, A.B., Glick, A.B., Luckert, P.H., Pollard, M. (1992). Interactions of Retinoids and Transforming Growth Factor-Beta in the Chemoprevention of Cancer. In: Sporn, M.B. (eds) Control of Growth Factors and Prevention of Cancer. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77383-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77383-9_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77385-3

  • Online ISBN: 978-3-642-77383-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation